RCL
66
-8
STT
48
-3
MSFT
53
-4
PAYX
42
-9
HPE
16
-5
AAPL
61
-4
APA
45
-5
PM
43
-4
FOXA
31
-4
BK
66
-3
YUM
65
-3
BWA
49
-3
MTCH
44
-6
PLD
43
-5
NRG
75
-2
V
56
-6
NWS
62
-7
BRK.B
45
-2
BAC
36
-2
UAL
53
-5
RCL
66
-8
STT
48
-3
MSFT
53
-4
PAYX
42
-9
HPE
16
-5
AAPL
61
-4
APA
45
-5
PM
43
-4
FOXA
31
-4
BK
66
-3
YUM
65
-3
BWA
49
-3
MTCH
44
-6
PLD
43
-5
NRG
75
-2
V
56
-6
NWS
62
-7
BRK.B
45
-2
BAC
36
-2
UAL
53
-5
Financhill
Back

Tiziana Life Sciences 10K Form

Buy
63

TLSA
Tiziana Life Sciences

Last Price:
0.67
Seasonality Move:
35.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TLSA News And Ratings

See the #1 stock for the next 7 days that we like better than TLSA

TLSA Financial Statistics

Sales & Book Value

Annual Sales: $90K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.13
Price / Book: 0

Profitability

EPS (TTM): -0.18200
Net Income (TTM): $-19.5M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Tiziana Life Sciences Earnings Forecast

Key Tiziana Life Sciences Financial Ratios

  • The Selling, General & Administrative Expenses for TLSA have been equal to 77.78% of Gross Profit Margin.
  • The Interest Expense is -0.05% of Operating Income.
  • Per Share Earnings over the last 25 years have been positive in 16 years.

Tiziana Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TLSA
CUSIP: 88875G
Website: tizianalifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TLSA Technical Analysis vs Fundamental Analysis

Buy
63
Tiziana Life Sciences (TLSA) is a Buy

Is Tiziana Life Sciences a Buy or a Sell?